×

CellRapeutics™ Serum from Multiple Sclerosis Donor (XS-0426-XU132)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sourced from donors with chronic demyelinating disease of the central nervous system, this serum reflects a complex neuro-inflammatory state. It contains circulating markers of axonal damage and specific cytokine profiles associated with Th1/Th17 effector responses. It serves as a vital tool for identifying peripheral biomarkers of disease activity and monitoring blood-brain barrier integrity.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ Serum from Multiple Sclerosis Donor
  • Cat. No.
  • XS-0426-XU132
  • Donor Age
  • Young Adult
  • Donor Health
  • Clinically diagnosed with Multiple Sclerosis. Serum reflects a neuro-inflammatory state, containing systemic signatures of demyelination and altered cytokine profiles associated with central nervous system autoimmunity.
  • Ethnicity
  • Predominantly Caucasian.
  • Anticoagulant
  • None (separated via centrifugation following natural coagulation).
  • Additional Donor Information
  • Each lot features serum from donors with MS. Profiles include clinical subtype, MRI lesion burden, and history of B-cell depleting or other disease-modifying therapies.
  • Clinical Profile
  • Clinical subtype, EDSS score, current relapse status, and history of disease-modifying therapies.

Additional Information

  • Medication History
  • Available upon request. Records of Disease-Modifying Therapies including Interferons, B-cell depleting agents, S1P receptor modulators, and acute relapse treatment with high-dose corticosteroids.
  • Formulation
  • Frozen
  • Cell Viability
  • Cell-free (no residual erythrocytes or leukocytes).
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each serum batch undergoes rigorous IRB-compliant screening, ensuring pathogen-free safety, consistent physicochemical properties, and standardized clinical characterization of disease-specific biomarkers to provide a reliable, high-purity biological matrix.
  • Storage
  • Store at -80°C or below for long-term stability, or at -20°C for up to 6 months, avoid repeated freeze-thaw cycles to preserve product quality.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Thaw slowly on ice or at 4°C and centrifuge to remove cryoprecipitates, immediate aliquoting upon first thaw is recommended to maintain autoantibody functional integrity.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • 1ML
  • Keywords
  • CellRapeutics™ Serum from Multiple Sclerosis Donor, Serum, Multiple Sclerosis

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Serum from Multiple Sclerosis Donor (XS-0426-XU132). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.